246 related articles for article (PubMed ID: 29107274)
1. Focal Ablation of Early-Stage Prostate Cancer: Candidate Selection, Treatment Guidance, and Assessment of Outcome.
Edison E; Tariq Shah T; Ahmed HU
Urol Clin North Am; 2017 Nov; 44(4):575-585. PubMed ID: 29107274
[TBL] [Abstract][Full Text] [Related]
2. New advances in focal therapy for early stage prostate cancer.
Tay KJ; Schulman AA; Sze C; Tsivian E; Polascik TJ
Expert Rev Anticancer Ther; 2017 Aug; 17(8):737-743. PubMed ID: 28635336
[TBL] [Abstract][Full Text] [Related]
3. Prostate Radiofrequency Focal Ablation (ProRAFT) Trial: A Prospective Development Study Evaluating a Bipolar Radiofrequency Device to Treat Prostate Cancer.
Orczyk C; Barratt D; Brew-Graves C; Peng Hu Y; Freeman A; McCartan N; Potyka I; Ramachandran N; Rodell R; Williams NR; Emberton M; Ahmed HU
J Urol; 2021 Apr; 205(4):1090-1099. PubMed ID: 33315505
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer: state of the art imaging and focal treatment.
Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
Clin Radiol; 2017 Aug; 72(8):665-679. PubMed ID: 28385253
[TBL] [Abstract][Full Text] [Related]
5. Utility of Multiparametric MRI for Predicting Residual Clinically Significant Prostate Cancer After Focal Laser Ablation.
Felker ER; Raman SS; Lu DSK; Tuttle M; Margolis DJ; ElKhoury FF; Sayre J; Marks LS
AJR Am J Roentgenol; 2019 Dec; 213(6):1253-1258. PubMed ID: 31361529
[No Abstract] [Full Text] [Related]
6. Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial.
Scheltema MJ; van den Bos W; de Bruin DM; Wijkstra H; Laguna MP; de Reijke TM; de la Rosette JJ
BMC Cancer; 2016 May; 16():299. PubMed ID: 27150293
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial.
Ghai S; Perlis N; Lindner U; Hlasny E; Haider MA; Finelli A; Zlotta AR; Kulkarni GS; van der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J
Eur Radiol; 2018 Oct; 28(10):4281-4287. PubMed ID: 29696431
[TBL] [Abstract][Full Text] [Related]
8. New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.
Valerio M; Cerantola Y; Eggener SE; Lepor H; Polascik TJ; Villers A; Emberton M
Eur Urol; 2017 Jan; 71(1):17-34. PubMed ID: 27595377
[TBL] [Abstract][Full Text] [Related]
9. How to select the right patients for focal therapy of prostate cancer?
Passoni NM; Polascik TJ
Curr Opin Urol; 2014 May; 24(3):203-8. PubMed ID: 24625428
[TBL] [Abstract][Full Text] [Related]
10. Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort.
Blazevski A; Scheltema MJ; Yuen B; Masand N; Nguyen TV; Delprado W; Shnier R; Haynes AM; Cusick T; Thompson J; Stricker P
Eur Urol Oncol; 2020 Jun; 3(3):283-290. PubMed ID: 31103721
[TBL] [Abstract][Full Text] [Related]
11. An update on focal therapy for prostate cancer.
Perera M; Krishnananthan N; Lindner U; Lawrentschuk N
Nat Rev Urol; 2016 Nov; 13(11):641-653. PubMed ID: 27670618
[TBL] [Abstract][Full Text] [Related]
12. Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer.
Eggener SE; Yousuf A; Watson S; Wang S; Oto A
J Urol; 2016 Dec; 196(6):1670-1675. PubMed ID: 27449263
[TBL] [Abstract][Full Text] [Related]
13. Surveillance after prostate focal therapy.
Tay KJ; Amin MB; Ghai S; Jimenez RE; Kench JG; Klotz L; Montironi R; Muto S; Rastinehad AR; Turkbey B; Villers A; Polascik TJ
World J Urol; 2019 Mar; 37(3):397-407. PubMed ID: 29948045
[TBL] [Abstract][Full Text] [Related]
14. Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the United States.
Taneja SS; Bennett J; Coleman J; Grubb R; Andriole G; Reiter RE; Marks L; Azzouzi AR; Emberton M
J Urol; 2016 Oct; 196(4):1096-104. PubMed ID: 27291652
[TBL] [Abstract][Full Text] [Related]
15. Targeted prostate biopsy and MR-guided therapy for prostate cancer.
Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
Abdom Radiol (NY); 2016 May; 41(5):877-88. PubMed ID: 26907717
[TBL] [Abstract][Full Text] [Related]
16. Focal ablation of prostate cancer: four roles for magnetic resonance imaging guidance.
Sommer G; Bouley D; Gill H; Daniel B; Pauly KB; Diederich C
Can J Urol; 2013 Apr; 20(2):6672-81. PubMed ID: 23587506
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance image-guided focal laser ablation in clinically localized prostate cancer: safety and efficacy.
Al-Hakeem Y; Raz O; Gacs Z; Maclean F; Varol C
ANZ J Surg; 2019 Dec; 89(12):1610-1614. PubMed ID: 31679182
[TBL] [Abstract][Full Text] [Related]
18. Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic Outcomes.
Collettini F; Enders J; Stephan C; Fischer T; Baur ADJ; Penzkofer T; Busch J; Hamm B; Gebauer B
Radiology; 2019 Jul; 292(1):250-257. PubMed ID: 31161973
[TBL] [Abstract][Full Text] [Related]
19. MRI Findings After MRI-Guided Focal Laser Ablation of Prostate Cancer.
Westin C; Chatterjee A; Ku E; Yousuf A; Wang S; Thomas S; Fan X; Eggener S; Karczmar G; Oto A
AJR Am J Roentgenol; 2018 Sep; 211(3):595-604. PubMed ID: 29995499
[TBL] [Abstract][Full Text] [Related]
20. Nanoknife Electroporation Ablation Trial: A Prospective Development Study Investigating Focal Irreversible Electroporation for Localized Prostate Cancer.
Valerio M; Dickinson L; Ali A; Ramachadran N; Donaldson I; Mccartan N; Freeman A; Ahmed HU; Emberton M
J Urol; 2017 Mar; 197(3 Pt 1):647-654. PubMed ID: 27697580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]